• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Value of protocols of alternating chemotherapy versus melphalan-prednisone during the induction phase of stage III myelomas. Critical review].

作者信息

Paule B, Medicis P, Clerc D, Bennet P, Bisson M, Massias P

机构信息

Service de Rhumatologie, Hôpital Kremlin-Bicêtre.

出版信息

Rev Rhum Mal Osteoartic. 1987 Dec;54(12):827-32.

PMID:3324290
Abstract
摘要

相似文献

1
[Value of protocols of alternating chemotherapy versus melphalan-prednisone during the induction phase of stage III myelomas. Critical review].
Rev Rhum Mal Osteoartic. 1987 Dec;54(12):827-32.
2
[Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].[采用美法仑、泼尼松、环磷酰胺、长春新碱和卡氮芥治疗II期和III期多发性骨髓瘤（M-2方案）]
Rev Clin Esp. 1985 May;176(8):392-5.
3
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.卡莫司汀（BCNU）、环磷酰胺和泼尼松间歇性给药与美法仑和泼尼松间歇性给药治疗骨髓瘤的Ⅲ期研究
Cancer Treat Rep. 1982 Jun;66(6):1273-7.
4
Combination chemotherapy versus melphalan and prednisone in multiple myeloma.
Chemioterapia. 1987 Jun;6(2 Suppl):725-6.
5
[Multiple myeloma. Clinical experience of 15 years in the 10th region].
Rev Med Chil. 1987 Nov;115(11):1061-5.
6
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.美法仑、泼尼松联合沙利度胺治疗75岁以上新诊断多发性骨髓瘤患者的疗效：IFM 01/01试验
J Clin Oncol. 2009 Aug 1;27(22):3664-70. doi: 10.1200/JCO.2008.21.0948. Epub 2009 May 18.
7
Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
Cancer Treat Rep. 1984 Dec;68(12):1439-46.
8
[Evaluation of the prognosis and response to therapy in multiple myeloma].
Recenti Prog Med. 1984 May;75(5):451-61.
9
Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.美法仑和泼尼松联合长春新碱、卡莫司汀、美法仑、环磷酰胺及泼尼松治疗多发性骨髓瘤的比较：东部肿瘤协作组E2479研究结果
Cancer. 1997 Apr 15;79(8):1561-7.
10
Multiple myeloma in a child.
Ceylon Med J. 1987 Sep;32(3):143-5.